Aptevo Therapeutics Inc.Aptevo Therapeutics Inc.Aptevo Therapeutics Inc.

Aptevo Therapeutics Inc.

No trades
See on Supercharts
Market capitalization
‪1.14 M‬USD
−72.0716USD
‪−17.41 M‬USD
‪1.60 M‬
Beta (1Y)
2.36

About Aptevo Therapeutics Inc.

CEO
Marvin L. White
Headquarters
Seattle
Employees (FY)
40
Founded
2016
FIGI
BBG009RRZ8C2
Aptevo Therapeutics, Inc. is a clinical-stage biotechnology company, which focuses on developing novel immunotherapies for the treatment of cancer. Its pipeline APVO436, ALG.APV-527 and APVO603 were developed based on the ADAPTIR modular protein platform technology and APVO442 was developed based on the new ADAPTIR-FLE platform technology. The ADAPTIR and ADAPTIR-FLEX are capable of generating differentiated bispecific and multi-specific antibodies with potentially unique mechanisms of action for the treatment of different types of cancer. The company was founded in February 2016 and is headquartered in Seattle, WA.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬

See all ideas 

Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

The current price of APVO is 0.7362 USD — it has increased by 3.69% in the past 24 hours.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Aptevo Therapeutics Inc. stocks are traded under the ticker APVO.
Aptevo Therapeutics Inc. is going to release the next earnings report on May 9, 2024. Keep track of upcoming events with our Earnings Calendar.
APVO stock is 9.23% volatile and has beta coefficient of 2.36. Check out the list of the most volatile stocks — is Aptevo Therapeutics Inc. there?
APVO earnings for the last quarter are −22.00 USD per share, whereas the estimation was −28.16 USD resulting in a 21.88% surprise. The estimated earnings for the next quarter are −19.80 USD per share. See more details about Aptevo Therapeutics Inc. earnings.
Aptevo Therapeutics Inc. revenue for the last quarter amounts to ‪3.11 M‬ USD despite the estimated figure of ‪3.75 M‬ USD. In the next quarter revenue is expected to reach ‪3.45 M‬ USD.
Yes, you can track Aptevo Therapeutics Inc. financials in yearly and quarterly reports right on TradingView.
APVO stock has fallen by 5.62% compared to the previous week, the month change is a 84.13% fall, over the last year Aptevo Therapeutics Inc. has showed a 99.10% decrease.
APVO net income for the last quarter is ‪−5.90 M‬ USD, while the quarter before that showed ‪−6.33 M‬ USD of net income which accounts for 6.80% change. Track more Aptevo Therapeutics Inc. financial stats to get the full picture.
Today Aptevo Therapeutics Inc. has the market capitalization of ‪1.14 M‬, it has decreased by 30.23% over the last week.
No, APVO doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
Like other stocks, APVO shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Aptevo Therapeutics Inc. stock right from TradingView charts — choose your broker and connect to your account.
APVO reached its all-time high on Jul 27, 2016 with the price of 5106.6400 USD, and its all-time low was 0.7000 USD and was reached on Apr 17, 2024.
See other stocks reaching their highest and lowest prices.
As of Apr 24, 2024, the company has 40.00 employees. See our rating of the largest employees — is Aptevo Therapeutics Inc. on this list?
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Aptevo Therapeutics Inc. technincal analysis shows the sell today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Aptevo Therapeutics Inc. stock shows the sell signal. See more of Aptevo Therapeutics Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
We've gathered analysts' opinions on Aptevo Therapeutics Inc. future price: according to them, APVO price has a max estimate of 20.00 USD and a min estimate of 10.50 USD. Read a more detailed Aptevo Therapeutics Inc. forecast: see what analysts think of Aptevo Therapeutics Inc. and suggest that you do with its stocks.